Cargando…

Key differences identified between actinic keratosis and cutaneous squamous cell carcinoma by transcriptome profiling

BACKGROUND: Cutaneous squamous cell carcinoma (cSCC) is one of the most common malignancies in fair-skinned populations worldwide and its incidence is increasing. Despite previous observations of multiple genetic abnormalities in cSCC, the oncogenic process remains elusive. The purpose of this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Lambert, S R, Mladkova, N, Gulati, A, Hamoudi, R, Purdie, K, Cerio, R, Leigh, I, Proby, C, Harwood, C A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899778/
https://www.ncbi.nlm.nih.gov/pubmed/24335922
http://dx.doi.org/10.1038/bjc.2013.760
_version_ 1782300624392552448
author Lambert, S R
Mladkova, N
Gulati, A
Hamoudi, R
Purdie, K
Cerio, R
Leigh, I
Proby, C
Harwood, C A
author_facet Lambert, S R
Mladkova, N
Gulati, A
Hamoudi, R
Purdie, K
Cerio, R
Leigh, I
Proby, C
Harwood, C A
author_sort Lambert, S R
collection PubMed
description BACKGROUND: Cutaneous squamous cell carcinoma (cSCC) is one of the most common malignancies in fair-skinned populations worldwide and its incidence is increasing. Despite previous observations of multiple genetic abnormalities in cSCC, the oncogenic process remains elusive. The purpose of this study was to elucidate key molecular events associated with progression from premalignant actinic keratoses (AKs) to invasive cSCC by transcriptome profiling. METHODS: We combined laser capture microdissection with the Affymetrix HGU133 Plus 2.0 microarrays to profile 30 cSCC and 10 AKs. RESULTS: We identified a core set of 196 genes that are differentially expressed between AK and cSCC, and are enriched for processes including epidermal differentiation, cell migration, cell-cycle regulation and metabolism. Gene set enrichment analysis highlighted a key role for the mitogen activated protein kinase (MAPK) pathway in cSCC compared with AK. Furthermore, the histological subtype of the tumour was shown to influence the expression profile. CONCLUSION: These data indicate that the MAPK pathway may be pivotal to the transition from AK to cSCC, thus representing a potential target for cSCC prevention. In addition, transcriptome differences identified between cSCC subtypes have important implications for future development of targeted therapies for this malignancy.
format Online
Article
Text
id pubmed-3899778
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-38997782015-01-21 Key differences identified between actinic keratosis and cutaneous squamous cell carcinoma by transcriptome profiling Lambert, S R Mladkova, N Gulati, A Hamoudi, R Purdie, K Cerio, R Leigh, I Proby, C Harwood, C A Br J Cancer Genetics and Genomics BACKGROUND: Cutaneous squamous cell carcinoma (cSCC) is one of the most common malignancies in fair-skinned populations worldwide and its incidence is increasing. Despite previous observations of multiple genetic abnormalities in cSCC, the oncogenic process remains elusive. The purpose of this study was to elucidate key molecular events associated with progression from premalignant actinic keratoses (AKs) to invasive cSCC by transcriptome profiling. METHODS: We combined laser capture microdissection with the Affymetrix HGU133 Plus 2.0 microarrays to profile 30 cSCC and 10 AKs. RESULTS: We identified a core set of 196 genes that are differentially expressed between AK and cSCC, and are enriched for processes including epidermal differentiation, cell migration, cell-cycle regulation and metabolism. Gene set enrichment analysis highlighted a key role for the mitogen activated protein kinase (MAPK) pathway in cSCC compared with AK. Furthermore, the histological subtype of the tumour was shown to influence the expression profile. CONCLUSION: These data indicate that the MAPK pathway may be pivotal to the transition from AK to cSCC, thus representing a potential target for cSCC prevention. In addition, transcriptome differences identified between cSCC subtypes have important implications for future development of targeted therapies for this malignancy. Nature Publishing Group 2014-01-21 2013-12-12 /pmc/articles/PMC3899778/ /pubmed/24335922 http://dx.doi.org/10.1038/bjc.2013.760 Text en Copyright © 2014 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/3.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
spellingShingle Genetics and Genomics
Lambert, S R
Mladkova, N
Gulati, A
Hamoudi, R
Purdie, K
Cerio, R
Leigh, I
Proby, C
Harwood, C A
Key differences identified between actinic keratosis and cutaneous squamous cell carcinoma by transcriptome profiling
title Key differences identified between actinic keratosis and cutaneous squamous cell carcinoma by transcriptome profiling
title_full Key differences identified between actinic keratosis and cutaneous squamous cell carcinoma by transcriptome profiling
title_fullStr Key differences identified between actinic keratosis and cutaneous squamous cell carcinoma by transcriptome profiling
title_full_unstemmed Key differences identified between actinic keratosis and cutaneous squamous cell carcinoma by transcriptome profiling
title_short Key differences identified between actinic keratosis and cutaneous squamous cell carcinoma by transcriptome profiling
title_sort key differences identified between actinic keratosis and cutaneous squamous cell carcinoma by transcriptome profiling
topic Genetics and Genomics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899778/
https://www.ncbi.nlm.nih.gov/pubmed/24335922
http://dx.doi.org/10.1038/bjc.2013.760
work_keys_str_mv AT lambertsr keydifferencesidentifiedbetweenactinickeratosisandcutaneoussquamouscellcarcinomabytranscriptomeprofiling
AT mladkovan keydifferencesidentifiedbetweenactinickeratosisandcutaneoussquamouscellcarcinomabytranscriptomeprofiling
AT gulatia keydifferencesidentifiedbetweenactinickeratosisandcutaneoussquamouscellcarcinomabytranscriptomeprofiling
AT hamoudir keydifferencesidentifiedbetweenactinickeratosisandcutaneoussquamouscellcarcinomabytranscriptomeprofiling
AT purdiek keydifferencesidentifiedbetweenactinickeratosisandcutaneoussquamouscellcarcinomabytranscriptomeprofiling
AT cerior keydifferencesidentifiedbetweenactinickeratosisandcutaneoussquamouscellcarcinomabytranscriptomeprofiling
AT leighi keydifferencesidentifiedbetweenactinickeratosisandcutaneoussquamouscellcarcinomabytranscriptomeprofiling
AT probyc keydifferencesidentifiedbetweenactinickeratosisandcutaneoussquamouscellcarcinomabytranscriptomeprofiling
AT harwoodca keydifferencesidentifiedbetweenactinickeratosisandcutaneoussquamouscellcarcinomabytranscriptomeprofiling